lncRNA ENST00000422059 promotes cell proliferation and inhibits cell apoptosis in breast cancer by regulating the miR-145-5p/KLF5 axis
暂无分享,去创建一个
Yiping Zhu | Yuxin Jiang | Xu Wu | Jinwen Xu | Yulei Li | Junling Ren | Yuan Zhang | Ying Wang | Qiuyu Tan
[1] Yunjun Xiao,et al. Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer , 2023, Cellular and Molecular Life Sciences.
[2] Zhongxin Lu,et al. LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer , 2023, Journal of Experimental & Clinical Cancer Research.
[3] A. Jemal,et al. Cancer statistics, 2023 , 2023, CA: a cancer journal for clinicians.
[4] Howard Y. Chang,et al. Inducible lncRNA transgenic mice reveal continual role of HOTAIR in promoting breast cancer metastasis , 2022, eLife.
[5] Haibo Zhang,et al. DANCR Induces Cisplatin Resistance of Triple-Negative Breast Cancer by KLF5/p27 Signaling. , 2022, The American journal of pathology.
[6] Hailin Tang,et al. The FUS/circEZH2/KLF5/ feedback loop contributes to CXCR4-induced liver metastasis of breast cancer by enhancing epithelial-mesenchymal transition , 2022, Molecular Cancer.
[7] Yeting He,et al. ceRNA network of lncRNA MIR210HG/miR-377-3p/LMX1A in malignant proliferation of glioma cells , 2022, Genes & Genomics.
[8] C. Yuan,et al. MicroRNA-145-5p modulates Krüppel-like factor 5 and inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma , 2022, BMC molecular and cell biology.
[9] D. Koundal,et al. Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures , 2022, BioMed research international.
[10] V. Yang,et al. KLF5 protects the intestinal epithelium against Th17 immune response in a murine colitis model , 2022, JCI insight.
[11] Chao Yao,et al. SNHG1/miR-145-5p/KLF5 Axis Participates in Regulating the Proliferation and Migration of Oral Squamous Cell Cancer , 2022, Journal of healthcare engineering.
[12] S. Saha,et al. Breast cancer: presentation, investigation and management. , 2022, British journal of hospital medicine.
[13] J. Peng,et al. YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer , 2022, Cell Death & Differentiation.
[14] N. Lin,et al. Global challenges and policy solutions in breast cancer control. , 2022, Cancer treatment reviews.
[15] X. Shan,et al. Krüppel-like factor 5 promotes the progression of oral squamous cell carcinoma via the baculoviral IAP repeat containing 5 gene , 2022, Annals of translational medicine.
[16] K. Guo,et al. LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150-5p , 2021, Cell Death & Disease.
[17] Yixuan Hou,et al. A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties , 2021, Journal of Hematology & Oncology.
[18] Xiaoting Lin,et al. lncRNA ITGB8-AS1 functions as a ceRNA to promote colorectal cancer growth and migration through integrin-mediated focal adhesion signaling , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.
[19] Kathryn P Trayes,et al. Breast Cancer Treatment. , 2021, American family physician.
[20] Zhongmei Zhou,et al. KLF5-induced lncRNA IGFL2-AS1 promotes basal-like breast cancer cell growth and survival by upregulating the expression of IGFL1. , 2021, Cancer letters.
[21] W. Koch,et al. KLF5 Is Induced by FOXO1 and Causes Oxidative Stress and Diabetic Cardiomyopathy. , 2020, Circulation research.
[22] Yiping Zhu,et al. lncRNA CERS6-AS1 as ceRNA promote cell proliferation of breast cancer by sponging miR-125a-5p to upregulate BAP1 expression. , 2020, Molecular carcinogenesis.
[23] Xin-yang Wang,et al. KLF5 inhibits STAT3 activity and tumor metastasis in prostate cancer by suppressing IGF1 transcription cooperatively with HDAC1 , 2020, Cell Death & Disease.
[24] Xiaoyan Li,et al. LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis , 2020, Molecular Cancer.
[25] Rui Xia,et al. KLF5 and MYC modulated LINC00346 contributes to gastric cancer progression through acting as a competing endogeous RNA and indicates poor outcome , 2019, Cell Death & Differentiation.
[26] Taicheng Zhou,et al. miR‐145‐5p affects the differentiation of gastric cancer by targeting KLF5 directly , 2018, Journal of cellular physiology.
[27] Qifeng Yang,et al. LncRNA–CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA‐215 , 2018, Journal of cellular physiology.
[28] Jinfeng Yang,et al. miR‑145‑5p reduces proliferation and migration of hepatocellular carcinoma by targeting KLF5. , 2018, Molecular medicine reports.
[29] Ming-jun Sun,et al. LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR‐20a‐5p/HMGA2 axis in breast cancer , 2018, Cancer medicine.
[30] Zhongmei Zhou,et al. BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5 , 2015, Nature Communications.
[31] S. Inoue,et al. Krüppel-like factor 5 in human breast carcinoma: a potent prognostic factor induced by androgens. , 2012, Endocrine-related cancer.
[32] L. Fan,et al. Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China , 2009, Breast Cancer Research and Treatment.
[33] G. Heinze,et al. Expression of KLF5 is a Prognostic Factor for Disease-Free Survival and Overall Survival in Patients with Breast Cancer , 2006, Clinical Cancer Research.
[34] R. Giegerich,et al. Fast and effective prediction of microRNA/target duplexes. , 2004, RNA.